Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (1481-1490 of 6,943) with videos related to

Pageof 695
Sort By:
Cancer Science|October 26, 2012
Early response and local control of stage I non-small-cell lung cancer after stereotactic radiotherapy: difference by histologyAkifumi Miyakawa, Yuta Shibamoto, Katsura Kosaki, et al.
Cancer Science|October 31, 2012
Arsenic trioxide prevents nitric oxide production in lipopolysaccharide -stimulated RAW 264.7 by inhibiting a TRIF-dependent pathwayMiyuki Takahashi, Akinobu Ota, Sivasundaram Karnan, et al.
Cancer Science|July 28, 2020
A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinomaMasatoshi Kudo, Manabu Morimoto, Michihisa Moriguchi, et al.
Cancer Science|August 9, 2020
DRP1 promotes lactate utilization in KRAS-mutant non-small-cell lung cancer cellsMangze Hu, Yu Zhao, Yuejiao Cao, et al.
Cancer Science|August 12, 2020
Development of adoptive immunotherapy with KK-LC-1-specific TCR-transduced γδT cells against lung cancer cellsYoshinobu Ichiki, Yoshiki Shigematsu, Tetsuro Baba, et al.
Cancer Science|July 22, 2020
Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironmentXiaolong Zhang, Qinli Ruan, Yiqian Zhai, et al.
Cancer Science|July 15, 2020
Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patientsKeiichi Hatakeyama, Takeshi Nagashima, Keiichi Ohshima, et al.
Cancer Science|July 19, 2020
Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global studyTakashi Seto, Hidetoshi Hayashi, Miyako Satouchi, et al.
Cancer Science|August 1, 2020
MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinibAkihiro Nishiyama, Shinji Takeuchi, Yuta Adachi, et al.
Cancer Science|August 5, 2020
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomasNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
Pageof 695

Showing results (1481-1490 of 6,943) with videos related to

Sort By:
Pageof 695
Cancer Science|October 26, 2012
Early response and local control of stage I non-small-cell lung cancer after stereotactic radiotherapy: difference by histologyAkifumi Miyakawa, Yuta Shibamoto, Katsura Kosaki, et al.
Cancer Science|October 31, 2012
Arsenic trioxide prevents nitric oxide production in lipopolysaccharide -stimulated RAW 264.7 by inhibiting a TRIF-dependent pathwayMiyuki Takahashi, Akinobu Ota, Sivasundaram Karnan, et al.
Cancer Science|July 28, 2020
A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinomaMasatoshi Kudo, Manabu Morimoto, Michihisa Moriguchi, et al.
Cancer Science|August 9, 2020
DRP1 promotes lactate utilization in KRAS-mutant non-small-cell lung cancer cellsMangze Hu, Yu Zhao, Yuejiao Cao, et al.
Cancer Science|August 12, 2020
Development of adoptive immunotherapy with KK-LC-1-specific TCR-transduced γδT cells against lung cancer cellsYoshinobu Ichiki, Yoshiki Shigematsu, Tetsuro Baba, et al.
Cancer Science|July 22, 2020
Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironmentXiaolong Zhang, Qinli Ruan, Yiqian Zhai, et al.
Cancer Science|July 15, 2020
Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patientsKeiichi Hatakeyama, Takeshi Nagashima, Keiichi Ohshima, et al.
Cancer Science|July 19, 2020
Lorlatinib in previously treated anaplastic lymphoma kinase-rearranged non-small cell lung cancer: Japanese subgroup analysis of a global studyTakashi Seto, Hidetoshi Hayashi, Miyako Satouchi, et al.
Cancer Science|August 1, 2020
MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinibAkihiro Nishiyama, Shinji Takeuchi, Yuta Adachi, et al.
Cancer Science|August 5, 2020
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomasNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.
Pageof 695